JP2013505966A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505966A5
JP2013505966A5 JP2012531124A JP2012531124A JP2013505966A5 JP 2013505966 A5 JP2013505966 A5 JP 2013505966A5 JP 2012531124 A JP2012531124 A JP 2012531124A JP 2012531124 A JP2012531124 A JP 2012531124A JP 2013505966 A5 JP2013505966 A5 JP 2013505966A5
Authority
JP
Japan
Prior art keywords
lower alkyl
group
compound
carbon atoms
soluble non
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012531124A
Other languages
English (en)
Japanese (ja)
Other versions
JP5792175B2 (ja
JP2013505966A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/050761 external-priority patent/WO2011056325A2/en
Publication of JP2013505966A publication Critical patent/JP2013505966A/ja
Publication of JP2013505966A5 publication Critical patent/JP2013505966A5/ja
Application granted granted Critical
Publication of JP5792175B2 publication Critical patent/JP5792175B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012531124A 2009-09-29 2010-09-29 オリゴマー−カルシミメティクスコンジュゲートおよび関連化合物 Active JP5792175B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24693109P 2009-09-29 2009-09-29
US61/246,931 2009-09-29
PCT/US2010/050761 WO2011056325A2 (en) 2009-09-29 2010-09-29 Oligomer-calcimimetic conjugates and related compounds

Publications (3)

Publication Number Publication Date
JP2013505966A JP2013505966A (ja) 2013-02-21
JP2013505966A5 true JP2013505966A5 (enExample) 2013-11-14
JP5792175B2 JP5792175B2 (ja) 2015-10-07

Family

ID=43901165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012531124A Active JP5792175B2 (ja) 2009-09-29 2010-09-29 オリゴマー−カルシミメティクスコンジュゲートおよび関連化合物

Country Status (9)

Country Link
EP (1) EP2482855B1 (enExample)
JP (1) JP5792175B2 (enExample)
KR (1) KR101828613B1 (enExample)
CN (1) CN102573921B (enExample)
AU (1) AU2010315805B2 (enExample)
CA (1) CA2773353C (enExample)
IL (1) IL218869A (enExample)
MX (1) MX341690B (enExample)
WO (1) WO2011056325A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722732B2 (en) 2009-09-29 2014-05-13 Nektar Therapeutics Oligomer-calcimimetic conjugates and related compounds
JP2020105072A (ja) * 2017-03-24 2020-07-09 協和キリン株式会社 ポリエチレングリコール誘導体
US20220040318A1 (en) * 2018-09-28 2022-02-10 Seikagaku Corporation Primary amine compound or secondary amine compound-acidic polysaccharide conjugate and production method therefor
EP4212542A4 (en) * 2020-09-10 2024-08-28 Shaanxi Micot Technology Co., Ltd. BISPECIFIC FUSION POLYPEPTIDE COMPOUND

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966988A (en) 1989-02-17 1990-10-30 Chevron Research Company Process for preparing acetonitrile 3-trifluoromethyl benzene
US6011068A (en) 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
WO1996012697A2 (en) 1994-10-21 1996-05-02 Nps Pharmaceuticals, Inc. Calcium receptor-active compounds
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5648541A (en) 1995-09-28 1997-07-15 Nps Pharmaceuticals, Inc. Chiral reductions of imines leading to the syntheses of optically active amines
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
PL1694363T3 (pl) 2003-12-16 2014-07-31 Nektar Therapeutics Monodyspersyjne kompozycje PEGylowanego naloksolu
JP4773436B2 (ja) 2005-05-16 2011-09-14 テバ ファーマシューティカル インダストリーズ リミティド シナカルセト塩酸塩の調製方法
EP2279758B1 (en) 2005-06-16 2015-02-25 Nektar Therapeutics Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
WO2007062147A1 (en) 2005-11-22 2007-05-31 Teva Pharmaceutical Industries Ltd. Crystal forms of cinacalcet hci and processes for their preparation
EP1928817A1 (en) 2006-04-27 2008-06-11 Teva Pharmaceutical Industries Ltd Process for the preparation of cinacalcet base
CA2681582C (en) * 2007-03-30 2015-07-14 Amgen Inc. Methods of treating bowel disorders
US11033631B2 (en) * 2008-06-09 2021-06-15 Nektar Therapeutics Methods of treating CYP2D6 alternative metabolizers

Similar Documents

Publication Publication Date Title
JP2011528654A5 (enExample)
JP2013500256A5 (enExample)
JP2010527913A5 (enExample)
JP2011511075A5 (enExample)
JP5249016B2 (ja) タキサン類の高分子結合体
JP5951496B2 (ja) ポリマー−薬物コンジュゲートの酸性塩形態及びアルコキシル化方法
JP2018518201A5 (enExample)
JP2005532287A5 (enExample)
JP2003511422A5 (enExample)
JP2010516844A5 (ja) 硬化性接着剤組成物
JP2005534660A5 (enExample)
JP2012502990A5 (enExample)
JP2011516700A5 (enExample)
JP2008511601A5 (enExample)
JP2010509379A5 (enExample)
JP2009203483A5 (enExample)
JP2013505966A5 (enExample)
JP2008533191A5 (enExample)
JP2008538381A5 (enExample)
JP2014503548A5 (enExample)
JP2008024929A5 (enExample)
JP2013514329A5 (enExample)
JP2013542981A5 (enExample)
US20150297772A1 (en) Composition for odor removal and fragrance emission comprising complexes of cucurbituril and fragrance
JP2007532627A5 (enExample)